We are live on ! Find out more
MIST icon

Milestone Pharmaceuticals
MIST

50 hedge funds and large institutions have $85.5M invested in Milestone Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 16 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

77% more call options, than puts

Call options by funds: $840K | Put options by funds: $474K

6% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 16

5.25% less ownership

Funds ownership: 70.47% → 65.22% (-5.2%)

11% less funds holding

Funds holding: 56 → 50 (-6)

11% less capital invested

Capital invested by funds: $96.2M → $85.5M (-$10.6M)

50% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 12

Holders
50
Holders Change
-6
Holders Change %
-10.71%
% of All Funds
0.8%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
15
Reduced
16
Closed
12
Calls
$840K
Puts
$474K
Net Calls
+$366K
Net Calls Change
-$1.11M

Top Buyers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$1.46M
2
BlackRock
BlackRock
New York
+$1.27M
3
AFA
Alta Fundamental Advisers
New York
+$1.22M
4
Barclays
Barclays
United Kingdom
+$751K
5
BC
BIT Capital
Germany
+$500K

Top Sellers

1
B
Braidwell
Connecticut
-$4.61M
2
RI
RTW Investments
New York
-$3.87M
3
Morgan Stanley
Morgan Stanley
New York
-$1.8M
4
PVI
Pura Vida Investments
New York
-$1.47M
5
Millennium Management
Millennium Management
New York
-$972K
Name Holding Trade Value Shares
Change 		Change in
Stake
LP
26
LMR Partners
United Kingdom
$152K – – –
CCFM
27
Clear Creek Financial Management
Washington
$142K +$131K +35,929 New
Two Sigma Investments
28
Two Sigma Investments
New York
$139K -$581K -159,036 -82%
HighTower Advisors
29
HighTower Advisors
Illinois
$103K +$95.8K +26,200 New
BFM
30
Boothbay Fund Management
New York
$99.2K – – –
State Street
31
State Street
Massachusetts
$86.7K -$344 -94 -0.4%
Geode Capital Management
32
Geode Capital Management
Massachusetts
$69.2K – – –
Envestnet Asset Management
33
Envestnet Asset Management
Illinois
$64.7K +$8.45K +2,311 +16%
PAM
34
PVG Asset Management
Colorado
$62.4K +$57.9K +15,835 New
Two Sigma Advisers
35
Two Sigma Advisers
New York
$56.3K -$127K -34,800 -71%
Creative Planning
36
Creative Planning
Kansas
$51.5K – – –
XT
37
XTX Topco
Cayman Islands
$49.8K -$208K -56,820 -82%
Walleye Trading
38
Walleye Trading
New York
$49.3K -$78.4K -21,452 -63%
Susquehanna International Group
39
Susquehanna International Group
Pennsylvania
$48.8K +$45.3K +12,386 New
FDCDDQ
40
Federation des caisses Desjardins du Quebec
Quebec, Canada
$41.4K – – –
OQS
41
Occudo Quantitative Strategies
Florida
$41.2K -$105K -28,668 -73%
Osaic Holdings
42
Osaic Holdings
Arizona
$39.8K +$26.4K +7,212 +250%
CSS
43
Cubist Systematic Strategies
Connecticut
$35.1K -$300K -81,974 -90%
UBS Group
44
UBS Group
Switzerland
$10.9K -$8.82K -2,413 -47%
BNP Paribas Financial Markets
45
BNP Paribas Financial Markets
France
$8.47K +$2.38K +651 +43%
Group One Trading
46
Group One Trading
Illinois
$953 -$111K -30,385 -99%
National Bank of Canada
47
National Bank of Canada
Quebec, Canada
$395 – – –
IGWM
48
ICA Group Wealth Management
Colorado
$394 +$366 +100 New
MWM
49
Mascoma Wealth Management
New Hampshire
$363 – – –
B
50
Braidwell
Connecticut
– -$4.61M -1,164,849 Closed
1
2
3

MIST Hedge Fund Activity: Q1 2023 in Review

50 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Milestone Pharmaceuticals (MIST) for Q1 2023, worth a combined $85.5M — down 11% from $96.2M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of MIST and 6 opened new positions — a net loss of 6 holders — while 16 trimmed existing stakes and 15 added.

The largest buyer was Point72 Asset Management, adding an estimated $1.46M. The largest seller was Braidwell, exiting entirely with an estimated $4.61M sold.

  • 50 institutional investors held Milestone Pharmaceuticals (MIST) as of Q1 2023, down from 56 in Q4 2022.
  • Funds reported $85.5M of Milestone Pharmaceuticals stock for Q1 2023, down 11% quarter-over-quarter.
  • 6 funds opened new Milestone Pharmaceuticals positions in Q1 2023 and 12 closed out, a net change of -6 holders.
  • The largest Milestone Pharmaceuticals buyer in Q1 2023 was Point72 Asset Management, an estimated $1.46M added.
  • The largest Milestone Pharmaceuticals seller in Q1 2023 was Braidwell, an estimated $4.61M sold.

Based on aggregated 13F filings for Q1 2023.